Search Results

Pharmacokinetics and pharmacokinetic/pharmacodynamic relationships for angiotensin-converting enzyme inhibitors

Authors: P. L. TOUTAIN; H. P. LEFÈBVRE

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 27, Number 6, December 2004 , pp. 515-525(11)

Publisher: Blackwell Publishing

Inhibition study of angiotensin converting enzyme by capillary electrophoresis after enzymatic reaction at capillary inlet

Authors: Van Dyck S.; Novakova S.; Van Schepdael A.; Hoogmartens J.

Source: Journal of Chromatography A, Volume 1013, Number 1, 26 September 2003 , pp. 149-156(8)

Publisher: Elsevier

Pharmacokinetic/pharmacodynamic modelling of the disposition and effect of benazepril and benazeprilat in cats

Authors: King J.N.; Maurer M.; Toutain P.L.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 26, Number 3, June 2003 , pp. 213-224(12)

Publisher: Blackwell Publishing

Quantitative determination of benazepril and benazeprilat in human plasma by gas chromatography-mass spectrometry using automated 96-well disk plate solid-phase extraction for sample preparation

Authors: Pommier F.; Boschet F.; Gosset G.

Source: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, Volume 783, Number 1, 5 January 2003 , pp. 199-205(7)

Publisher: Elsevier

Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats

Authors: King, J. N.; Strehlau, G.; Wernsing, J.; Brown, S. A.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 25, Number 5, October 2002 , pp. 371-378(8)

Publisher: Blackwell Publishing

Kinetics of the acidic and enzymatic hydrolysis of benazepril HCl studied by LC

Authors: Gana M.; Panderi I.; Parissi-Poulou M.; Tsantili-Kakoulidou A.

Source: Journal of Pharmaceutical and Biomedical Analysis, Volume 27, Number 1, 1 January 2002 , pp. 107-116(10)

Publisher: Elsevier

Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease

Authors: Sica D.A.; Gehr T.W.B.; Fernandez A.

Source: Drug Safety, Volume 22, Number 5, May 2000 , pp. 350-360(11)

Publisher: Adis International

Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl

Authors: King; Humbert-Droz; Maurer

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 22, Number 6, December 1999 , pp. 360-367(8)

Publisher: Blackwell Publishing

Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension - meta-analysis of randomized double-blind studies

Authors: Virdis A.; Ghiadoni L.; Marzilli M.; Orsini E.; Favilla S.; Duranti P.; Taddei S.; Marraccini P.; Salvetti A.

Source: Journal of the American College of Cardiology, Volume 33, Number 6, May 1999 , pp. 1677-1684(8)

Publisher: Elsevier

Protection of Renal Function with ACE Inhibitors: Experience with Benazepril

Authors: Aldigier J.C.; Meur Y.L.; Brunel P.

Source: Clinical Drug Investigation, Volume 16, Number 6, 1 December 1998 , pp. 463-472(10)

Publisher: Adis International

Stereoselective analysis of benazepril and its stereoisomers by reversed-phase high-performance liquid chromatography on a chiral AGP column

Authors: Cirilli R.; La Torre F.

Source: Journal of Chromatography A, Volume 818, Number 1, 28 August 1998 , pp. 53-60(8)

Publisher: Elsevier

Effects of Valsartan and Hydrochlorothiazide Alone and in Combination on Blood Pressure and Heart Rate in Conscious-Telemetered Spontaneously Hypertensive Rats (SHR)

Authors: Webb R.L.; Navarrete A.E.; Davis S.

Source: American Journal of Hypertension, Volume 11, Number 1, January 1998 , pp. 59-65(7)

Publisher: Elsevier

Angiotensin converting enzyme inhibition, AT₁ receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns

Authors: Krombach R.S.; Clair M.J.; Hendrick J.W.; Houck W.V.; Zellner J.L.; Kribbs S.B.; Whitebread S.; Mukherjee R.; de Gasparo M.; Spinale F.G.

Source: Cardiovascular Research, Volume 38, Number 3, June 1998 , pp. 631-645(15)

Publisher: Elsevier

Amlodipine and benazeprilat differently affect the responses to endothelin-1 and bradykinin in porcine ciliary arteries: effects of a low and high dose combination

Authors: Lang M.G.; Zhu P.; Meyer P.; Noll G.; Haefliger I.O.; Flammer J.; Lüscher T.F.

Source: Current Eye Research, Volume 16, Number 3, March 1997 , pp. 208-213(6)

Publisher: Informa Healthcare

Pharmacokinetics of the angiotensin-convertingenzym e inhibitor, benazepril, and its active metabolite, benazeprilat, in dog

Authors: King J. N.; Maurer M.; Morrison C. A.; Mauron C.; Kaiser G.

Source: Xenobiotica, Volume 27, Number 8, 1 August 1997 , pp. 819-829(11)

Publisher: Informa Healthcare

Benazepril and benazeprilat binding to albumin and serum proteins

Authors: Bilenky S.M.; Giunti C.; Kim C.W.; Colussi D.; Caron C.; Godbillon J.

Source: European Journal of Pharmaceutical Sciences, Volume 4, Number 3, May 1996 , pp. 139-145(7)

Publisher: Elsevier

Site-Differential Gastrointestinal Absorption of Benazepril Hydrochloride in Healthy Volunteers

Authors: Chan K.K.H.; Buch A.; Glazer R.D.; John V.A.; Barr W.H.

Source: Pharmaceutical Research, Volume 11, Number 3, March 1994 , pp. 432-437(6)

Publisher: Springer

Steady-State Pharmacokinetics and Pharmacodynamics of Benazeprilat in Spontaneously Hypertensive Rats (SHR) and Wistar–Kyoto (WKY) Rats

Authors: LeRoy S.; Berner B.

Source: Pharmaceutical Research, Volume 8, Number 7, July 1991 , pp. 883-887(5)

Publisher: Springer